A carregar...
A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products
There have been several new treatment approaches established for the management of hyperglycemia in type 2 diabetes (T2D), with treatment guidelines listing both glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and basal insulin therapies as considerations for patients who have failed to contro...
Na minha lista:
| Publicado no: | Ther Adv Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5813858/ https://ncbi.nlm.nih.gov/pubmed/29492243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018817752315 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|